Xeris Biopharma Holdings, Inc.

By person

14 insiders · 34 transactions

33.1×

John Shannon holds 33.1 times base salary in stock. $24.64M of shares against $742.33K in salary for 2025.

Salary from the company's own proxy. The shares are what John Shannon last reported holding, valued at $8.50, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hecht Beth

See Remarks

—

$1.31M (12) scheduled

−$1.31M

1,127,796

0.6186%

$9.59M

−18.9%

McCulloch Kevin

See Remarks

—

$1.09M (4) scheduled

−$1.09M

1,664,208

0.9128%

$14.15M

+1.4%

JOHNSON JOHN

Director

—

$1.07M (2)

−$1.07M

707,276

0.3879%

$6.01M

−20.6%

Pieper Steven

See Remarks

—

$468.18K (4) scheduled

−$468.18K

1,356,053

0.7438%

$11.53M

−4.8%

Shannon John Patrick Jr

See Remarks

—

$349.66K (2) scheduled

−$349.66K

2,898,933

1.59%

$24.64M

+34.5%

BORMANN-KENNEDY BARBARA-JEAN ANNE

Director

—

$203.92K (2) scheduled

−$203.92K

150,693

0.0827%

$1.28M

+40.2%

HALKUFF DAWN

Director

—

$121.89K (1) scheduled

−$121.89K

119,193

0.0654%

$1.01M

+10.9%

PERSKY MARLA

Director

—

$91.43K (1) scheduled

−$91.43K

150,693

0.0827%

$1.28M

+40.2%

Brady James Aloysius

Director

—

$60.04K (1) scheduled

−$60.04K

113,359

0.0622%

$963.55K

—

Nguyen Anh Tu

See Remarks

—

395,023

0.2167%

$3.36M

+30.4%

JOHNSON KENNETH ERLAND

See Remarks

—

320,446

0.1758%

$2.72M

−14.4%

Kong Garheng

Director

—

238,337

0.1307%

$2.03M

+45.2%

SHERMAN JEFFREY W

Director

—

219,188

0.1202%

$1.86M

+33.3%

KREHER NERISSA

Director

—

33,582

0.0184%

$285.45K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Pieper Steven

1 Sep 2026

See Remarks

Sold on a plan

5,000

$8.50

$42.50K

Hecht Beth

1 Sep 2026

See Remarks

Sold on a plan

16,666

$8.49

$141.43K

McCulloch Kevin

1 Sep 2026

See Remarks

Sold on a plan

15,000

$8.49

$127.31K

Pieper Steven

12 Aug 2026

See Remarks

Sold on a plan

5,000

$8.50

$42.50K

Hecht Beth

3 Aug 2026

See Remarks

Sold on a plan

16,666

$8.01

$133.55K

McCulloch Kevin

3 Aug 2026

See Remarks

Sold on a plan

15,000

$8.02

$120.24K

Pieper Steven

7 Jul 2026

See Remarks

Sold on a plan

27,600

$8.52

$235.28K

Pieper Steven

6 Jul 2026

See Remarks

Sold on a plan

17,400

$8.50

$147.90K

Hecht Beth

1 Jul 2026

See Remarks

Sold on a plan

16,666

$8.03

$133.86K

McCulloch Kevin

1 Jul 2026

See Remarks

Sold on a plan

90,000

$8.03

$722.51K

JOHNSON JOHN

4 Jun 2026

Director

Sold on a plan

15,000

$6.09

$91.42K

BORMANN-KENNEDY BARBARA-JEAN ANNE

4 Jun 2026

Director

Sold on a plan

16,000

$6.09

$97.51K

HALKUFF DAWN

4 Jun 2026

Director

Sold on a plan

20,000

$6.09

$121.89K

PERSKY MARLA

3 Jun 2026

Director

Sold on a plan

15,500

$5.90

$91.43K

Hecht Beth

1 Jun 2026

See Remarks

Sold on a plan

16,667

$6.06

$100.98K

Hecht Beth

1 May 2026

See Remarks

Sold on a plan

16,667

$6.23

$103.81K

Hecht Beth

1 Apr 2026

See Remarks

Sold on a plan

16,667

$5.99

$99.86K

Brady James Aloysius

30 Mar 2026

Director

Sold on a plan

10,834

$5.54

$60.04K

Hecht Beth

2 Mar 2026

See Remarks

Sold on a plan

100

$7.06

$706.00

Hecht Beth

2 Mar 2026

See Remarks

Sold on a plan

16,567

$6.24

$103.38K

McCulloch Kevin

8 Jan 2026

See Remarks

Sold on a plan

15,000

$8.00

$120.00K

Hecht Beth

2 Jan 2026

See Remarks

Sold on a plan

16,667

$7.43

$123.78K

BORMANN-KENNEDY BARBARA-JEAN ANNE

12 Dec 2025

Director

Sold on a plan

15,000

$7.09

$106.41K

Hecht Beth

1 Dec 2025

See Remarks

Sold on a plan

16,667

$7.01

$116.78K

Hecht Beth

11 Nov 2025

See Remarks

Sold on a plan

16,667

$7.40

$123.30K

Show all 34 transactions →

Xeris Biopharma Holdings, Inc.

By person

Individual transactions

What was left out